Late stent thrombosis, endothelialisation and drug-eluting stents

Netherlands Heart Journal

Volumn 17, Issue 4, 2009, Pages 177-180

  Ertas G ^a,b   Van Beusekom, H M ^a   Van Der Giessen, W J ^a,c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b KOCAELI UNIVERSITY   (Turkey)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

Drug eluting stents; Endothelial function; Endothelium; Stent thrombosis

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ANGIOSCOPY; AUTOPSY; BARE METAL STENT; CORONARY ARTERY; CORONARY STENT; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; EXPERIMENTAL MODEL; HEALING; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; NONHUMAN; PATHOGENESIS; REVIEW; STENT THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 70349267581     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03086242     Document Type: Review

References (31)

1. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-1780 (Pubitemid 34586912)
2. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong MK, et al. A paclitaxel-eluting stent for the prevention of coronary stenosis. N Engl J Med 2003;348:1537-1545
3. Collected-DES papers. Sections "perspectives", "original articles" and "editorial". N Engl J Med 2007;356:981-1039,1059- 1060
4. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation 2007;115:2435-2441 (Pubitemid 46717966)
5. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006;47:2108-2111
6. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins, KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007;356:998-1008. (Pubitemid 46376800)
7. Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007;370:937-948 (Pubitemid 47393576)
8. Garg P, Cohen DJ, Gaziano T, Mauri L. Balancing the risks of restenosis and stent thrombosis in bare-metal versus drug-eluting stents: results of a decision analytic model. J Am Coll Cardiol 2008;51:1844-1853 (Pubitemid 351615257)
9. Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007;369:667-678 (Pubitemid 46281313)
10. Wenaweser P, Daemen J, Zwahlen M, van Domburg R, Jüni P, Vaina S, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. J Am Coll Cardiol 2008;52:1134-1140
11. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029 (Pubitemid 46376802)
12. Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation 2007;116:910-916 (Pubitemid 47300915)
13. Awata M, Nanto S, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Angioscopic comparison of neointimal coverage between zotarolimus and sirolimus-eluting stents. J Am Coll Cardiol 2008;52:787-792
14. van Beusekom HM, Whelan DM, Hofma SH, Krabbendam SC, van Hinsbergh VW, Verdouw PD, et al. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries. J Am Coll Cardiol 1998;32:1109-1117
15. Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, et al. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338-345
16. Farb A, Burke AP, Kolodgie FD, Virmani R. Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 2003;108: 1701-1706 (Pubitemid 37243657)
17. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202. (Pubitemid 43929240)
18. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, et al. Drug-eluting stents show delayed healing: paclitaxel more pronounced than sirolimus. Eur Heart J 2007;28:974-979 (Pubitemid 47343915)
19. Takase B, Hamabe A, Satomura K, Akima T, Uehata A, Matsui T, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J 2006;70:49-56. (Pubitemid 43021234)
20. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-954 (Pubitemid 30131694)
21. Hofma SH, van der Giessen WJ, van Dalen BM, Lemos PA, McFadden EP, Sianos G, et al. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006;27:166-170 (Pubitemid 43069032)
22. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, et al. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005;46:231-236 (Pubitemid 40966848)
23. Togni M, Räber L, Cocchia R, Wenaweser P, Cook S, Windecker S, et al. Local vascular dysfunction after coronary paclitaxel-eluting stent implantation. Int J Cardiol 2007;120:212-220 (Pubitemid 47042255)
24. Shin DI, Kim PJ, Seung KB, Kim DB, Kim MJ, Chang K, et al. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction: comparison between sirolimus-eluting stent and paclitaxel-eluting stent. Int Heart J 2007;48:553-567 (Pubitemid 350200179)
25. Sorop O, Batenburg WW, Koopmans S-J, Dekker R, Duncker D, Danser A, et al. Taxus but not Cypher drug eluting stents induce endothelial dysfunction in the distal coronary microvasculature. Circulation 2007;116: II-293.
26. Li J, Jabara R, Pendyala L, Otsuka Y, Shinke T, Hou D, et al. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents. J Am Coll Cardiol Intv 2008;1:279-285
27. Onuma Y, van Beusekom HM, Sorop O, van der Giessen WJ. The paradigm of endothelium and stent thrombosis in DES. EuroIntervention 2008;4: 17-21.
28. Suzuki T, Kopia G, Hayashi S, Bailey LR, Llanos G, Wilensky R, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-1193 (Pubitemid 32830406)
29. Klugherz BD, Llanos G, Lieuallen W, Kopia GA, Papandreou G, Narayan P et al. Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent. Coron Artery Dis 2002;13:183-188 (Pubitemid 34747967)
30. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005;112:270-278 (Pubitemid 40982311)
31. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, et al. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008;52:333-342 (Pubitemid 352001347)